| Prev Close: | 72.30 |
|---|---|
| Open: | 71.85 |
| Bid: | 70.24 x 200 |
| Ask: | 74.98 x 200 |
| 1y Target Est: | 74.80 |
| Beta: | 0.8 |
| Next Earnings Date: | 15-Jul-13 |
| Day's Range: | 71.45 - 72.29 |
|---|---|
| 52wk Range: | 48.98 - 73.95 |
| Volume: | 3,260,278 |
| Avg Vol (3m): | 3,616,190 |
| Market Cap: | 39.10B |
| P/E (ttm): | 17.43 |
| EPS (ttm): | 4.14 |
| Div & Yield: | 1.96 (2.70%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Final Glance: Pharmaceuticals companiesAP(Thu, May 23)
- Final Glance: Medical Devices companiesAP(Thu, May 23)
- Labs reject dramatic findings on cancer drug in Alzheimer's miceat Reuters(Thu, May 23)
- Midday Glance: Medical Devices companiesAP(Thu, May 23)
- Midday Glance: Pharmaceuticals companiesAP(Thu, May 23)
- CTRX, STJ, CI, TMO And BAX, Pushing Health Services Industry Downwardat TheStreet(Thu, May 23)
- Early Glance: Pharmaceuticals companiesAP(Thu, May 23)
- Early Glance: Medical Devices companiesAP(Thu, May 23)
- Baxter to Present at the Goldman Sachs 34th Annual Global Healthcare ConferenceBusiness Wire(Thu, May 23)
- Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industryat Seeking Alpha(Wed, May 22)
- Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Failat Bloomberg(Wed, May 22)
- Daily Equity Brief: Bull Signals And Sentimentat Seeking Alpha(Wed, May 22)
- American Society Of Clinical Oncology Abstracts Point To Potential Profitsat Seeking Alpha(Tue, May 21)
- InPlay: Baxter receives marketing authorization for HyQvia in EUBriefing.com(Tue, May 21)
- Baxter Receives Marketing Authorization for HyQvia in European UnionBusiness Wire(Tue, May 21)
Press Releases
- Baxter to Present at the Goldman Sachs 34th Annual Global Healthcare ConferenceBusiness Wire(Thu, May 23)
- Baxter Receives Marketing Authorization for HyQvia in European UnionBusiness Wire(Tue, May 21)
- Baxter to Present at the Deutsche Bank 38th Annual dbAccess Health Care ConferenceBusiness Wire(Mon, May 20)
Reports
- BAX - Baxter International Inc - Rated a Hold - Company Analysis and ASR Ranking...Alpha Street Research(May 24)
- BAX: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 23)
- Baxter International Inc (BAX) Profile and Financials, plus Nanotechnology Industry...Plunkett Research, Ltd.(May 23)